Literature DB >> 7686098

Vanadium salts and the future treatment of diabetes.

Y Shechter1, A Shisheva.   

Abstract

Until the discovery of insulin by Banting and Best in 1922, diabetes had a high mortality rate. Since then regular administration of the drug has brought it under control. Nevertheless it is not an ideal drug, in that it has to be injected and because of the incidence of insulin resistance. There is, therefore, a need for alternative forms of treatment and in recent years interest has centred on the possibilities of vanadium salts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686098     DOI: 10.1016/0160-9327(93)90008-q

Source DB:  PubMed          Journal:  Endeavour        ISSN: 0160-9327            Impact factor:   0.444


  5 in total

Review 1.  Alternative therapies for diabetes and its cardiac complications: role of vanadium.

Authors:  Tod A Clark; Justin F Deniset; Clayton E Heyliger; Grant N Pierce
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

2.  The relationship between insulin and vanadium metabolism in insulin target tissues.

Authors:  F G Hamel; W C Duckworth
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 3.  Unique and selective mitogenic effects of vanadate on SV40-transformed cells.

Authors:  H Wang; R E Scott
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 4.  Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.

Authors:  J L Domingo; M Gomez; D J Sanchez; J M Llobet; C L Keen
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Decavanadate possesses alpha-adrenergic agonist activity and a structural motif common with trans-beta form of noradrenaline.

Authors:  B V Venkataraman; H N Ravishankar; A V Rao; P Kalyani; G Sharada; K Namboodiri; B Gabor; T Ramasarma
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.